Cannabinoid receptor type 1 antagonists alter aspects of risk/reward decision making independent of toluene-mediated effects

2021 ◽  
Author(s):  
Kevin M. Braunscheidel ◽  
Michael P. Okas ◽  
Stan B. Floresco ◽  
John J. Woodward
Keyword(s):  
Decision Making ◽  
Cannabinoid Receptor ◽  
Receptor Type ◽  
Mediated Effects ◽  
Cannabinoid Receptor Type 1

Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation

2019 ◽  
Vol 35 (3) ◽  
pp. 516-529 ◽  
Author(s):  
Fernanda Crunfli ◽  
Talita A. Vrechi ◽  
Andressa P. Costa ◽  
Andréa S. Torrão
Keyword(s):  
Cognitive Deficit ◽  
Cannabinoid Receptor ◽  
Receptor Type ◽  
Apoptosis Pathway ◽  
Cannabinoid Receptor Type 1

scholarly journals Regulation of MAP Kinase-Directed Mitogenic and Protein Kinase B-Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells

Diabetes ◽  
2009 ◽  
Vol 59 (2) ◽  
pp. 375-385 ◽  
Author(s):  
C. Lipina ◽  
C. Stretton ◽  
S. Hastings ◽  
J. S. Hundal ◽  
K. Mackie ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Protein Kinase ◽  
Map Kinase ◽  
Cannabinoid Receptor ◽  
Protein Kinase B ◽  
Muscle Cells ◽  
Skeletal Muscle Cells ◽  
Receptor Type ◽  
Cannabinoid Receptor Type 1

Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome

2017 ◽  
Vol 112 (6) ◽  
pp. 933-939 ◽  
Author(s):  
Andrzej Wasilewski ◽  
Urszula Lewandowska ◽  
Paula Mosinska ◽  
Cezary Watala ◽  
Martin Storr ◽  
...  
Keyword(s):  
Opioid Receptor ◽  
Cannabinoid Receptor ◽  
Mu Opioid Receptor ◽  
Receptor Type ◽  
Cyclic Vomiting Syndrome ◽  
Mu Opioid ◽  
Cannabinoid Receptor Type 1 ◽  
Cyclic Vomiting

Cannabinoid receptor type 1 in the bed nucleus of the stria terminalis modulates cardiovascular responses to stress via local N-methyl-D-aspartate receptor/neuronal nitric oxide synthase/soluble guanylate cyclase/protein kinase G signaling

2020 ◽  
Vol 34 (4) ◽  
pp. 429-440
Author(s):  
Lucas Gomes-de-Souza ◽  
Willian Costa-Ferreira ◽  
Leandro A Oliveira ◽  
Ricardo Benini ◽  
Carlos C Crestani
Keyword(s):  
Nitric Oxide ◽  
Receptor Antagonist ◽  
Restraint Stress ◽  
Cannabinoid Receptor ◽  
Cardiovascular Responses ◽  
Receptor Type ◽  
Stria Terminalis ◽  
Bed Nucleus ◽  
Cannabinoid Receptor Type 1

Background: Endocannabinoid neurotransmission in the bed nucleus of the stria terminalis is involved in the control of cardiovascular responses to stress. However, the local mechanisms involved is this regulation are not known. Aims: The purpose of this study was to assess an interaction of bed nucleus of the stria terminalis endocannabinoid neurotransmission with local nitrergic signaling, as well as to investigate the involvement of local N-methyl-D-aspartate glutamate receptor and nitric oxide signaling in the control of cardiovascular responses to acute restraint stress by bed nucleus of the stria terminalis endocannabinoid neurotransmission in rats. Methods: The first protocol evaluated the effect of intra-bed nucleus of the stria terminalis microinjection of the selective cannabinoid receptor type 1 receptor antagonist AM251 in nitrite/nitrate content in the bed nucleus of the stria terminalis following restraint stress. The other protocols evaluated the impact of local pretreatment with the selective N-methyl-D-aspartate glutamate receptor antagonist LY235959, the selective neuronal nitric oxide synthase inhibitor Nω-propyl-L-arginine, the soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, or the protein kinase G inhibitor KT5823 in restraint-evoked cardiovascular changes following bed nucleus of the stria terminalis treatment with AM251. Results: Bilateral microinjection of AM251 into the bed nucleus of the stria terminalis increased local nitric oxide release during restraint stress. Bed nucleus of the stria terminalis treatment with the cannabinoid receptor type 1 receptor antagonist also enhanced the tachycardia caused by restraint stress, but without affecting arterial pressure increase and sympathetic-mediated cutaneous vasoconstriction. The facilitation of restraint-evoked tachycardia following bed nucleus of the stria terminalis treatment with the cannabinoid receptor type 1 receptor antagonist was completely inhibited by local pretreatment with LY235959, Nω-propyl-L-arginine, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, or KT5823. Conclusions: Our results provide evidence that bed nucleus of the stria terminalis endocannabinoid neurotransmission inhibits local N-methyl-D-aspartate/neuronal nitric oxide synthase/soluble guanylate cyclase/protein kinase G signaling, and this mechanism is involved in the control of the cardiovascular responses to stress.

Cannabinoid receptor Type 1 densities reflect social organization in Microtus

2020 ◽  
Author(s):  
Trenton C. Simmons ◽  
Sara M. Freeman ◽  
Nicholas S. Lackey ◽  
Brooke K. Dreyer ◽  
Devanand S. Manoli ◽  
...  
Keyword(s):  
Social Organization ◽  
Cannabinoid Receptor ◽  
Receptor Type ◽  
Cannabinoid Receptor Type 1

Inverse agonist of ERRγ reduces cannabinoid receptor type 1-mediated induction of fibrinogen synthesis in mice with a high-fat diet-intoxicated liver

2018 ◽  
Vol 92 (9) ◽  
pp. 2885-2896 ◽  
Author(s):  
Yaochen Zhang ◽  
Don-Kyu Kim ◽  
Yoon Seok Jung ◽  
Yong-Hoon Kim ◽  
Yong Soo Lee ◽  
...  
Keyword(s):  
High Fat Diet ◽  
Cannabinoid Receptor ◽  
Inverse Agonist ◽  
Receptor Type ◽  
High Fat ◽  
Cannabinoid Receptor Type 1

Role of cannabinoid receptor type 1 in rostral ventrolateral medulla in high-fat diet-induced hypertension in rats

2018 ◽  
Vol 36 (4) ◽  
pp. 801-808 ◽  
Author(s):  
Guo-Qi Li ◽  
Zhe Wang ◽  
Tong Zhao ◽  
Shi-Xuan Dai ◽  
Jia-Ming Liu ◽  
...  
Keyword(s):  
High Fat Diet ◽  
Cannabinoid Receptor ◽  
Rostral Ventrolateral Medulla ◽  
Receptor Type ◽  
Ventrolateral Medulla ◽  
High Fat ◽  
Cannabinoid Receptor Type 1 ◽  
Induced Hypertension

scholarly journals Test–retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [11C]MePPEP

NeuroImage ◽  
2014 ◽  
Vol 97 ◽  
pp. 151-162 ◽  
Author(s):  
Daniela A. Riaño Barros ◽  
Colm J. McGinnity ◽  
Lula Rosso ◽  
Rolf A. Heckemann ◽  
Oliver D. Howes ◽  
...  
Keyword(s):  
Cannabinoid Receptor ◽  
Receptor Type ◽  
Cannabinoid Receptor Type 1
Sign in / Sign up

Export Citation Format

Share Document